OceanaGold Reports Voting Results from its 2025 Annual General and Special Meeting
VANCOUVER, BC, June 4, 2025 /PRNewswire/ - OceanaGold Corporation (TSX: OGC), (TSX: OTCQX) (TSX: OCANF) ("OceanaGold" or the "Company") is pleased to report the voting results from the Company's 2025 Annual General and Special Meeting of Shareholders (the "Annual Meeting") held today.
A total of 538,458,035 common shares were voted at the meeting, representing 77.12% of the votes attached to all outstanding common shares. Shareholders voted in favour of each of the items of business at the Annual Meeting as follows:
Election of Directors
Resolutions electing each of the director nominees listed in OceanaGold's Management Information Circular dated April 23, 2025 as directors of the Company were passed by ordinary resolution.
Detailed results of the vote for each director are set out in the table below:
Directors
Votes For
%
Votes Withheld / Abstain
%
Paul Benson
393,936,966
79.79
99,784,006
20.21
Ian M. Reid
488,729,245
98.99
4,991,727
1.01
Craig J. Nelsen
491,026,458
99.45
2,694,514
0.55
Sandra M. Dodds
482,121,086
97.65
11,599,886
2.35
Alan N. Pangbourne
490,403,457
99.33
3,317,515
0.67
Linda M. Broughton
491,015,000
99.45
2,705,972
0.55
Stefanie E. Loader
493,423,819
99.94
297,153
0.06
Gerard M. Bond
493,434,771
99.94
286,201
0.06
Share Consolidation
A special resolution approving the consolidation of all issued and outstanding common shares of the Company on a consolidation ratio of up to three (3) pre-consolidation common shares for one (1) post-consolidation common share (the "Consolidation") was passed.
Votes For
%
Votes Against
%
536,892,725
99.71
1,565,307
0.29
The Company is exploring the benefits of a dual listing of its common shares on a major U.S. exchange, including the New York Stock Exchange, for a potential listing in the first half of 2026. The Company believes a U.S. listing could lead to increased interest by a wider audience of potential investors and result in increased marketability and trading liquidity. The principal reason for the Consolidation is to raise the per share trading price of the common shares in order to better comply with minimum trading price requirements of such exchanges.
Subject to approval by the Toronto Stock Exchange, OceanaGold expects the Consolidation to be effective on or around June 23, 2025, and intends to issue a detailed press release to provide a further update and final details on the Consolidation.
Appointment of Auditor
A resolution appointing PricewaterhouseCoopers LLP (PWC Canada) as the auditor of the Company for the ensuing year and authorizing the board of the Company to fix their remuneration was passed.
Votes For
%
Votes Withheld / Abstain
%
508,912,534
94.51
29,545,500
5.49
Advisory Vote on Executive Compensation
A non-binding resolution on the Company's approach to executive compensation was passed.
Votes For
%
Votes Against
%
480,384,783
97.30
13,336,189
2.70
Virtual-Only Meetings
A resolution approving the Company to hold the 2026 Annual General Meeting of Shareholders exclusively in a virtual-only format was passed.
Votes For
%
Votes Against
%
325,303,717
65.89
168,417,253
34.11
Amendments to the Company's Articles
A special resolution approving amendments to the Company's articles was passed.
Votes For
%
Votes Against
%
491,746,774
99.60
1,974,197
0.40
About OceanaGold
OceanaGold is a growing intermediate gold and copper producer committed to safely and responsibly maximizing the generation of Free Cash Flow from our operations and delivering strong returns for our shareholders. We have a portfolio of four operating mines: the Haile Gold Mine in the United States of America; Didipio Mine in the Philippines; and the Macraes and Waihi operations in New Zealand.
Cautionary Statement for Public Release
This press release contains certain "forward-looking statements" and "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws which may include, but is not limited to, statements with respect to the Company being listed on a major U.S. exchange, including such dual listing leading to increased interest by a wider audience of potential investors, increased marketability and trading liquidity and the expected timing for such listing, and the anticipated timing and effects of the completion of the Consolidation. Forward-looking statements and information relate to future performance and reflect the Company's expectations regarding the generation of Free Cash Flow, execution of business strategy, future growth, future production, estimated costs, results of operations, business prospects and opportunities of OceanaGold and its related subsidiaries. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those expressed in the forward-looking statements. They include, among others, those risk factors identified in the Company's most recent Annual Information Form prepared and filed with securities regulators which is available on SEDAR+ at www.sedarplus.com under the Company's name and on the Company's website. There are no assurances the Company can fulfil forward-looking statements. Such forward-looking statements are only predictions based on current information available to management as of the date that such predictions are made; actual events or results may differ materially as a result of risks facing the Company, some of which are beyond the Company's control. Although the Company believes that any forward-looking statements contained in this press release is based on reasonable assumptions, readers cannot be assured that actual outcomes or results will be consistent with such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements and information, whether as a result of new information, events or otherwise, except as required by applicable securities laws.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oceanagold-reports-voting-results-from-its-2025-annual-general-and-special-meeting-302473774.html
SOURCE OceanaGold Corporation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
22 minutes ago
- Associated Press
UPDATE - Sono Group N.V. Reschedules Participation in Emerging Growth Conference to Tuesday, June 17, 2025
Munich, June 06, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. ( OTCQB: SEVCF ) (hereafter referred to as 'Sono Group' or 'Sono', parent company to Sono Motors GmbH or 'Sono Motors') today announced that its previously scheduled presentation at the Emerging Growth Conference on May 21, 2025, has been moved to the next event in the series. The Company will now present on Tuesday, June 17, 2025, from 1:45 PM to 2:15 PM Eastern Time. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Managing Director and CEO, George O'Leary, in real time. Mr. O'Leary will provide an update on the Company's strategy and recent developments, including the newly announced projects, the first quarter 2025 results published earlier this month, and key partnerships. Mr. O'Leary will give a presentation and may subsequently open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event and Mr. O'Leary will do his best to get through as many of them as possible. Please register here to ensure you are able to attend the conference and receive any updates that are released. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on the Company's investor relations website. In addition to the Emerging Growth Conference, Sono also confirms George O'Leary's participation in the upcoming Webull EV Webinar, taking place on Tuesday, June 24, 2025. Further details, including the agenda and registration link, will be provided closer to the date. 'Our recently published Q1 results demonstrate continued progress in our core business,' said George O'Leary. 'At the June 17 conference and at Webull EV Webinar on June 24, I look forward to sharing more about our momentum in the Sono business plans, our expanding partnerships, our new opportunities and an update on our planned uplisting to Nasdaq.' END ABOUT SONO GROUP N.V. Sono Group N.V. ( OTCQB: SEVCF ) and its wholly owned subsidiary Sono Motors GmbH are on a pioneering mission to accelerate the revolution of mobility by making every commercial vehicle solar. Our disruptive solar technology has been developed to enable seamless integration into all types of commercial vehicles to reduce the impact of CO2 emissions and pave the way for climate-friendly mobility. For more information about Sono Group N.V., Sono Motors, and their solar solutions, visit and Follow us on social media: LinkedIn, Facebook, BlueSky, Truth Social, and X. FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements. The words 'expect', 'anticipate', 'intend', 'plan', 'estimate', 'aim', 'forecast', 'project', 'target', 'will' and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding the intentions, beliefs, or current expectations of the Company and its subsidiary Sono Motors GmbH (together, the 'companies'). Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and could cause the companies' actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and assumptions include, but are not limited to, risks, uncertainties and assumptions with respect to: the Company's ability to uplist to the Nasdaq Capital Market, including meeting the initial listing requirements; the Company's ability to satisfy the conditions precedent set forth in its recent securities purchase agreement ('Securities Purchase Agreement') and exchange agreement ('Exchange Agreement') entered into with YA II PN, Ltd. ('Yorkville'); the timing of closing the transactions contemplated by the Securities Purchase Agreement and the Exchange Agreement; the impact of the transactions contemplated by the Exchange Agreement and Securities Purchase Agreement on the Company's operating results; our ability to maintain relationships with creditors, suppliers, service providers, customers, employees and other third parties in light of the performance and credit risks associated with our constrained liquidity position and capital structure; our ability to comply with OTCQB continuing standards; our ability to achieve our stated goals; our strategies, plan, objectives and goals, including, among others, the successful implementation and management of the pivot of our business to exclusively retrofitting and integrating our solar technology onto third party vehicles; our ability to raise the additional funding required beyond the investment from Yorkville to further develop and commercialize our solar technology and business as well as to continue as a going concern. For additional information concerning some of the risks, uncertainties and assumptions that could affect our forward-looking statements, please refer to our filings with the U.S. Securities and Exchange Commission ('SEC'), including our Annual Report on Form 20-F for the year ended December 31, 2023, which are accessible on the SEC's website at and on our website at Many of these risks and uncertainties relate to factors that are beyond our ability to control or estimate precisely, such as the actions of courts, regulatory authorities and other factors. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. Except as required by law, the Company assumes no obligation to update any such forward-looking statements. CONTACT SONO GROUP N.V. Press: [email protected] | Investors: [email protected] | LinkedIn:
Yahoo
25 minutes ago
- Yahoo
14 Top Press Releases from May
Including the latest ranking of the best places to live, big acquisition news from DICK's, and recaps for Mother's Day and Intersolar Europe. NEW YORK, June 6, 2025 /PRNewswire/ -- With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the month's most newsworthy and popular releases, here's a recap of some major stories from the last month that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. U.S. News Releases the 2025-2026 Best Places to Live RankingsNew data considerations and the expansion of evaluated cities resulted in a new top 10 for the 2025-2026 year, with Johns Creek, Georgia, taking No. 1 due to its strong job market and desirability scores. Mob Entertainment Signs Multi-Year Licensing Deal with Toy Giant McFarlane, Bringing Poppy Playtime Toys and Collectibles to Fans WorldwideThe collaboration will see McFarlane Toys bring Poppy Playtime's eerie yet beloved characters to life with an extensive range of products, including plushies, action figures, dioramas, prop replicas, and more. Scouting America Statement on the U.S. Court of Appeals for the Third Circuit Decision"The Court's decision is a resounding victory for survivors of historical abuse in Scouting, and it is the culmination of more than five years of tireless efforts by survivors, Scouting America, Local Councils, Chartered Organizations, settling insurance companies, and other stakeholders to equitably compensate survivors and preserve the mission of Scouting." Novo Nordisk announces that CVS Caremark®, the country's largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formulariesNovo Nordisk is focused on new ways to drive access and affordability for Wegovy®, the most widely prescribed and studied GLP-1 for weight loss that is fully available nationwide. Govee Launches New Strip Light with Skyline Kit, Turning Ceilings into Skylines of LightThe key innovation lies in its floating wall-washing effect, which projects a broad, upward glow that adds depth and dimension to any room. When mounted horizontally, the lighting creates a visual lift, bringing ceilings to life and transforming flat surfaces into luminous skylines. Stephan Tetrault Acquires GameStop CanadaThe acquisition marks a new chapter for the Canadian retailer, which will relaunch as EB Games Canada—a beloved and iconic name many Canadian gamers still associate with their earliest gaming experiences. The move reflects a commitment to revitalizing Canada's gaming retail scene, bringing renewed focus to customer experience, collector culture, and the unique preferences of Canadian gamers. FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesityIf approved, Wegovy® would become the first oral formulation of a GLP-1 indicated for chronic weight management. "We are entering a new era of obesity care where patients want individualized treatment plans that address their needs and provide choices, including oral formulations," said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc. DICK'S Sporting Goods to Acquire Foot Locker to Create a Global Leader in the Sports Retail Industry"Sports and sports culture continue to be incredibly powerful, and with this acquisition, we'll create a new global platform that serves those ever evolving needs through iconic concepts consumers know and love, enhanced store designs and omnichannel experiences, as well as a product mix that appeals to our different customer bases," said Lauren Hobart, President and CEO of DICK'S. Teamsters at Albertsons Vote Overwhelmingly to Authorize StrikeMore than 90 drivers demand fair pay, strong benefits, and protections against autonomous trucks. PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients"This funding fuels our mission to support more pharma, biotech, and CROs in embracing AI and machine learning to unlock the next era of clinical development. Our solutions deliver clear ROI by increasing trial success rates, reducing costs, and accelerating time to market," said Raviv Pryluk, PhD, CEO and Co-Founder of PhaseV. Fortune Reveals the 2025 100 Most Powerful Women in Business ListThe list, compiled by Fortune editors, is based on company size and health, as well as an executive's career trajectory, influence, innovation, and efforts to make business better. More than 50 women currently lead Fortune 500 companies, yet only 20 made this year's list—a testament to how increasingly competitive the ranking has become. Herring Networks Announces Multi-Year Content Carriage Agreement with SpectrumUnder the agreement, OAN and AWE will be added to Spectrum TV Select and TV Stream plans. In addition, OAN Live, the direct-to-consumer streaming platform, will be made available at no additional cost to Spectrum TV customers. G-SHOCK and Crocs Launch First-Ever Collaboration: Where Legendary Toughness Meets Street-Ready DesignThe release is the debut of Crocs Echo Wave silhouette in a glow-in-the-dark finish, marking the first partnership to feature this fan-favorite design. This exclusive design is enhanced by a custom marbled ankle strap inspired by G-SHOCK's iconic durability and precise craftsmanship. Cracker Barrel Commences Summertime with the Return of its Iconic Campfire MealsAfter seven long years, Cracker Barrel Old Country Store® is welcoming back the brand's beloved Campfire Meals – including an all new Campfire Shrimp Skillet, alongside Campfire Chicken and Campfire Beef, plus a new decadent S'mores Brownie Skillet featuring a HERSHEY'S Milk Chocolate Bar. Read more of the latest releases from PR Newswire. Trending Topics In addition to the newsworthy headlines above, the PR Newswire team identified several larger trending topics in May: Mother's Day: Companies in a variety of industries—from consumer to health, education and tech—shared news about how they were celebrating moms or doing their part to make moms' lives a little bit easier last month. Releases included maternity skincare brand HATCH Mama's debut at Ulta, a financial aid fund for student parents in college and AI-powered crying detection for Reolink's indoor monitors. Meanwhile, Medtronic worked to raise awareness for heart health among mothers and Life Time debuted family centered classes for mothers and their kids to build healthy habits. Summer Travel: As the weather heated up, the wire was filled with press releases about the latest summer travel trends, including top destinations, spending expectations and more. While Dave & Buster's and Urban Air offered ways to beat the heat this season, Boatsetter promoted outdoor adventures by declaring June 5 as National "Sorry I Was On a Boat Day." Beach destinations remain some of the most popular for summer travel, according to TripAdvisor (although some not-so-great bacteria levels could be an issue). A survey from Deloitte found that overall, 53% of Americans plan to travel and stay in paid lodging this summer. Intersolar Europe: The solar energy tradeshow took place in early May in Germany and exhibitors shared their PV innovations and event plans via PR Newswire. Headlines included an AI-powered energy storage system from Sungrow, a 10GW milestone for LONGi, several awards for PV module manufacturer PHONO Solar, and a balcony energy storage system from Growatt. Coming up: In June, the PR Newswire expects to see waves of press releases tied to big calendar events like Pride Month, Father's Day and Juneteenth. Plus, summer-related announcements in the food, travel and entertainment industries are likely to continue as the season heats up. Do you have a press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers, and freelancers have access to the following free features: Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story. Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles. Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at View original content to download multimedia: SOURCE PR Newswire
Yahoo
31 minutes ago
- Yahoo
GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World's First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy
HONG KONG, BEIJING and BOSTON, June 6, 2025 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology start-up company focusing on genome editing therapeutic solutions through the discovery of novel and precise Cas nucleases and the development of safe and efficient cargo delivery platforms, today announced a key milestone in the development of its pipeline: First patient has been dosed in an investigator-initiated trial (IIT) of GEB-101, the Company's leading in vivo genome editing program for TGFBI corneal dystrophy. The ongoing IIT is in collaboration with Prof Xingtao ZHOU, MD, PhD, Professor and President, and his team at the Eye & ENT Hospital of Fudan University in Shanghai, China. GEB-101 is a wholly owned program of GenEditBio. Preclinical assessment in non-human primates demonstrated that GEB-101 was well-tolerated after local intrastromal injection and had high safety profile with virtually undetectable off-target effect ( The preclinical research recently received the Excellence in Research Award at the 28th Annual Meeting of the American Society of Gene and Cell Therapy in May 2025 ( The IIT of GEB-101 is an open-label and dose-escalation clinical study to investigate the tolerability of GEB-101 when combined with standard treatment phototherapeutic keratectomy in adults with corneal dystrophy. The first patient, who received GEB-101 in May 2025, has been discharged from the collaborating hospital with no observable adverse event. This trial marks the world's first clinical study of an in vivo CRISPR-Cas ribonucleoprotein (RNP)-based genome editing investigational therapy for TGFBI corneal dystrophy. "Today, on National Sight Day, we are proud and honored to announce that we have initiated the world's first clinical study of an in vivo genome editing investigational therapy for corneal dystrophy. This key milestone represents years of effort in technology platform development and dedication from our world-class research team and clinical partners," said Zongli ZHENG, PhD, Chairman and Co-Founder of GenEditBio, "We stand at the frontier of a new era and recognize the transformative potential of this moment is not just for the Company but for the entire field of genetic medicine because the technology has the potential to extend far beyond corneal dystrophy. Our company is committed to developing fundamentally safe, efficacious and affordable in vivo genome editing therapies for genetic diseases with unmet medical needs". "This investigator-initiated trial marks a defining moment for our award-winning research team and clinical partners. Remarkably, in just one year since initiating our proof-of-concept and preclinical studies, we have successfully integrated our genome editing and delivery technologies to advance this pipeline program from the laboratory to clinical stage, showcasing our competence and dedication to rapidly translate basic research into clinical program to ultimately benefit patients," said Tian ZHU, PhD, CEO and Co-Founder of GenEditBio, "We also express our deepest gratitude to the participant who volunteers in this early stage trial to support medical innovation. As clinical data accumulate, we are positive that GEB-101 has the potential to become a new treatment option for patients with corneal dystrophy". About TGFBI Corneal Dystrophy TGFBI corneal dystrophy is a group of genetic eye disorders caused by mutations in the TGFBI gene, resulting in abnormal protein buildup in the stromal layer of cornea. Symptoms include photophobia, gradual vision loss and recurrent corneal erosions. Current treatment options include phototherapeutic keratectomy and corneal transplantation. These procedures, however, have known limitations such as recurrence and carry risks of sight-threatening complications, underscoring the need for novel therapies. About GEB-101 GEB-101, a wholly owned program of GenEditBio, is a genome editing drug candidate designed as a once-and-done treatment for TGFBI corneal dystrophy. GEB-101 is based on the CRISPR-Cas genome editing technology that targets a particular locus in the mutated TGFBI gene. GEB-101 is encapsulated in the form of RNP in engineered protein delivery vehicle (PDV), a proprietary in vivo delivery system developed by GenEditBio. GEB-101 is to be administered by intrastromal injection and is being investigated for tolerability in the IIT. About GenEditBio Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed "DNA surgery") with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company's core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston. GenEditBio is financially backed by top-tier life science investors, including Qiming Venture Partners, Fangyuan Capital, Center Biotherapeutics, Lumosa Therapeutics, HKSTP Venture Fund, and others. For more information, please visit Related Previous Press Releases GenEditBio Scientist Receives Excellence in Research Award at the 28th Annual Meeting of the American Society of Gene and Cell Therapy 2025 GenEditBio to Present Preclinical Data on its Delivery Technology Platform and Drug Pipeline at the 28th Annual Meeting of the American Society of Gene and Cell Therapy Media Contact: Investors Contact: bd@ View original content: SOURCE GenEditBio Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
